Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Advocacy: 2020 Year in Review

Blair Solow, MD  |  January 11, 2021

To say it has been an interesting (the science—and the memes!), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that I hope have kept everyone going. As we look to 2021, we take lessons from our experiences in 2020. Washington, D.C., is buzzing, with a new president, new members in the House and Senate, a new Congress (117th) and more COVID-19 legislation negotiations.

2020 Year in Review
A colossal thank you to our Government Affairs Committee members, patient advocates, physicians and interprofessional team member advocates for taking advocacy virtual last year during a pandemic and making it a huge success. I am so grateful for the ACR staff and advocates for taking a leap of faith and jumping all in to virtual advocacy. There were 3,061 emails sent to Congress on rheumatology issues, 2,052,710 #Act4Arthritis Twitter impressions and 285 meetings with legislators and ACR/ARP volunteers and patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Our ACR advocacy team in D.C. (Lennie Shewmaker, JD, director of congressional affairs; Amanda Grimm Wiegrefe, MScHSRA, director of regulatory affairs; and Dan Redinger, manager of advocacy and policy affairs) and in our Atlanta office (Adam Cooper, senior director of government affairs, and Joseph Cantrell, JD, senior manager of state affairs) will continue their efforts on behalf of ACR/ARP members, along with Rachel Myslinski, vice president of practice, advocacy and quality, and the rest of her team.

Add “make a RheumPAC investment” to your to-do list as a new year’s resolution! These funds allow for nonpartisan meetings with lawmakers working on issues that impact rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

2021 Physician Fee Schedule Final Rule
The win: The Centers for Medicare & Medicaid Services (CMS) finalized the 2021 Physician Fee Schedule Final Rule, with rheumatologists seeing an estimated boost in reimbursement of approximately 14-15%, to start in 2021. This was the second largest increase among all medical specialties.

Context: Each year, the CMS releases rules on physician reimbursement. They use recommendations from the American Medical Association’s Relative Value Scale Update Committee to guide decisions on how to pay physicians from a single pot of money. The CMS valued certain Current Procedural Terminology codes higher, including those often used by some subspecialties, and modified documentation requirements to reduce administrative burdens. In this zero-sum game, other specialties were not so fortunate, with losses in surgery, radiology and physical therapy. Given the pandemic and all practices struggling, recent COVID-19 legislation balanced the cuts some providers may see by adding $3 billion in new money, to increase Medicare Fee Schedule payments across the board by 3.75% in CY 2021.

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)legislation and advocacy

Related Articles

    The ACR’s 2020 Advocacy Year in Review

    February 16, 2021

    To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences